Page 17 - பல்கலைக்கழகம் ஆஃப் பிட்ஸ்பர்க் பள்ளி மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19 vaccination induces highly variable immunity among the immunocompromised Researchers in the United States have conducted a study showing that the humoral (antibody) immunity induced by vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – varies significantly among immunocompromised individuals. The findings come from an interim analysis of an ongoing observational, prospective cohort analysis called the COVID-19 Vaccination in the Immunocompromised Study (CoVICS), which began on April 14 th, 2021. Ghady Haidar and colleagues report that the presence of antibodies (seropositivity) against SARS-CoV-2 was significantly lower among certain groups of immunocompromised individuals compared with among healthy vaccinees.

United statesGhady haidarSally robertsonCenters for diseaseUniversity of pittsburgh school medicineUniversity of pittsburgh medical centerImmunocompromised studyPittsburgh schoolPittsburgh medical centerImmunocompromised patientsProspective cohort study interimImage creditDisease controlஒன்றுபட்டது மாநிலங்களில்சாலி ராபர்ட்சன்மையங்கள் க்கு நோய்